CanadaBis Capital Inc Market Cap ($1.53 Million)
Market Cap & Net Worth: CanadaBis Capital Inc (CANB)
CanadaBis Capital Inc market cap. CanadaBis Capital Inc (V:CANB) has a market capitalization of $1.53 Million (CA$2.12 Million) as of November 1, 2026. Listed on the V stock exchange, this Canada-based company holds position #30320 globally and #1511 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CanadaBis Capital Inc's stock price CA$0.02 by its total outstanding shares 141022815 (141.02 Million). Also see CANB cash flow metrics for how efficiently the company converts equity into cash flow.
CanadaBis Capital Inc Market Cap History (2017–2026)
CanadaBis Capital Inc market cap history from 2017 to 2026. Data shows change from $29.58 Million to $1.53 Million (-27.22% CAGR). Check CANB stock price for real-time trading data and today's change.
CanadaBis Capital Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CanadaBis Capital Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore CANB shareholders equity momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.18x
CanadaBis Capital Inc's market cap is 0.18 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $10.20 Million | $4.43 Million | -$5.39 Million | 2.30x | N/A |
| 2021 | $4.59 Million | $6.87 Million | -$2.68 Million | 0.67x | N/A |
| 2022 | $8.16 Million | $11.67 Million | $608.33K | 0.70x | 13.42x |
| 2023 | $26.01 Million | $22.22 Million | $4.44 Million | 1.17x | 5.85x |
| 2024 | $5.61 Million | $17.95 Million | -$84.06K | 0.31x | N/A |
| 2025 | $3.06 Million | $16.90 Million | -$835.20K | 0.18x | N/A |
Competitor Companies of CANB by Market Capitalization
Companies near CanadaBis Capital Inc in the global market cap rankings as of November 1, 2026. Also see CANB total assets for a full breakdown of the balance sheet.
Key companies related to CanadaBis Capital Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #511 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #535 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #593 globally with a market cap of $45.23 Billion USD ( CN¥309.13 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #511 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #535 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.62 |
| #593 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.23 Billion | CN¥48.46 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.30 |
Market Capitalization of CanadaBis Capital Inc (2017–2026)
Market capitalization of CanadaBis Capital Inc from 2017 to today. Between 2017 and today, CanadaBis Capital Inc's market cap moved from $29.58 Million to $ 1.53 Million, with a yearly change of -27.22%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$1.53 Million | -50.00% |
| 2025 | CA$3.06 Million | -45.45% |
| 2024 | CA$5.61 Million | -78.43% |
| 2023 | CA$26.01 Million | +218.75% |
| 2022 | CA$8.16 Million | +77.78% |
| 2021 | CA$4.59 Million | -55.00% |
| 2020 | CA$10.20 Million | -37.50% |
| 2019 | CA$16.32 Million | -55.56% |
| 2018 | CA$36.72 Million | +24.14% |
| 2017 | CA$29.58 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of CanadaBis Capital Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.53 Million USD |
| MoneyControl | $1.53 Million USD |
| MarketWatch | $1.53 Million USD |
| marketcap.company | $1.53 Million USD |
| Reuters | $1.53 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About CanadaBis Capital Inc
CanadaBis Capital Inc. engages in the production and sale of recreational cannabis and cannabis extracts in Canada. It operates through two segments: Cultivation and Extraction. The company cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. It is also involved in the production and wholesale distribution of cannabis extract products th… Read more